Form 4: IGM Biosciences Officer Steven Weber Reports Stock Transactions

Principal Accounting Officer Steven Weber of IGM Biosciences reported the acquisition of 18,750 restricted stock units and 37,500 stock options, as well as the disposal of 27,500 common stock shares.

Summary

• On March 12, 2024, Steven Weber, Principal Accounting Officer of IGM Biosciences, reported transactions involving the company's stock.
• Weber acquired 18,750 restricted stock units (RSUs), each representing a contingent right to receive one share of IGM Biosciences' common stock.
• These RSUs vest in installments, with one-sixteenth vesting on June 12, 2024, and then every three months thereafter, contingent upon continued service.
• Weber also acquired 37,500 stock options with an exercise price of $9.95.
• These options vest monthly, with one forty-eighth of the shares vesting on April 12, 2024, and each month thereafter, contingent upon continued service.
• Weber disposed of 27,500 shares of common stock.
• Following these transactions, Weber directly owns 27,500 shares of common stock and 37,500 stock options.
• The report was filed on March 14, 2024.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like officers and directors, trade their company's stock. It provides transparency into the transactions of those with access to non-public information.

Stakeholder Impact

• Shareholders are informed about the stock transactions of a key company officer.
• The transactions themselves may have a negligible impact on the stock price, but the disclosure provides transparency.

Key Dates